Skip to main content

Study challenges previous knowledge about amyloid beta protein

Images

Participants

Image
Natalia Carulla
Research Associate
Tel.+34 93 40 37123

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

The medical newspaper Diario Médico has echoed on   the research performed by Natàlia Carulla's group that has recently been published in Scientific Reports, a journal that belongs to the Nature group. The study offers data that challenge current views about the number and the shape of the first aggregates formed by amyloid beta protein, a molecule related to Alzheimer's disease.
 

Attachment:

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).